These findings suggest that the P193A mutation most likely affects the RNA-editing activity of ADAR1 p150 to some extent but not enough to induce phenotypic abnormalities, which might explain the reason why homozygous point mutations in Zα have not been identified in patients with AGS to date. The gene discussed is ADAR; the disease is Aicardi-Goutieres syndrome.